New Drug R&D

Products Dosage Forms Strengths Indications Status
Glipizide and Metformin HCl Capsules  Capsule  2.5 mg/250 mg  Type 2 diabetes mellitus  Obtained the new drug certificate 
Pirfenidone Tablets  Tablet  0.2 g  Idiopathic pulmonary fibrosis  In clinical tiral 
Omeprazole and Sodium Bicarbonate Capsules  Capsule  40 mg/1100 mg  Duodenal ulcer, Gastric ulcer  Clinical trial approved 
Lacosamide Tablets  Tablet  50 mg, 100 mg  Partial-onset seizures  Clinical trial approved 
Imidafenacin Tablets  Tablet  0.1 mg  Overactive Bladder  Clinical trial approved 
Minodronic Acid Tablets  Tablet  1 mg, 50 mg  Osteoporosis  Clinical trial approved 
Vilazodone Hydrochloride Tablets  Tablet  10 mg, 20 mg  Major depressive disorder  Clinical trial approved 
Ulipristal Acetate Tablets  Tablet  5 mg, 30 mg  Uterine fibroids, Emergency contraceptive   Clinical trial approved 
Erlotinib Hydrochloride Tablets  Tablet  25 mg, 100 mg, 150 mg  Non-small cell lung cancer, Pancreatic cancer  Clinical trial approved 
Ambrisentan Tablets  Tablet  5 mg, 10 mg  Pulmonary arterial hypertension  Clinical trial approved 
Almotriptan Malate Tablets  Tablet  6.25 mg, 12.5 mg  Migraine attacks  Clinical trial approved 
Topiroxostat Tablets  Tablet  20 mg, 40 mg, 60 mg  Hyperuricemia, Gout  Clinical trial approved 
Acotiamide Hydrochloride Tablets  Tablet  100 mg  Functional dyspepsia  Clinical trial approved 
Pitavastatin Calcium Tablets  Tablet  2 mg  Primary hyperlipidemia, Mixed dyslipidemia  In technical review 
Avanafil Tablets  Tablet  50 mg, 100 mg  Erectile dysfunction  Clinical trial approved 
第一页 1 2 最后页 



Copyright @ Beijing Hope Pharmaceutical Co., Ltd.